Literature DB >> 2784386

Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor.

P D Bonin1, G J Fici, J P Singh.   

Abstract

We report that interleukin-1 (IL-1) potentiates the proliferation of vascular smooth muscle cells. Growth of early passage smooth muscle cells was not significantly affected by IL-1 alone. Treatment with IL-1 together with the platelet derived growth factor (PDGF) or another polypeptide growth factor derived from mitogen activated human monocytes (MDGF) resulted in a significant enhancement of cell growth over either PDGF or MDGF alone. DNA synthesis was enhanced only marginally (30-40%) in quiescent cultures treated with an optimal concentration of IL-1 alone. In the presence of 5 units/ml of PDGF or MDGF, IL-1 produced about six- to eightfold higher DNA synthesis than the untreated cultures. Induction of DNA synthesis was linear between 0.1 and 1.0 pM IL-1, dependent on PDGF concentration, and was effectively neutralized by monoclonal antibodies against IL-1 beta. The growth promoting activity of IL-1 was extremely potent producing half-maximum stimulation at a concentration of 0.5 pM. These results suggest that IL-1 may play an important role in the modulation of growth and other activities of vascular smooth muscle cells. These observations are especially important with regard to defining the potential macrophage derived mediators contributing to vascular cell proliferation during inflammation and the pathogenesis of atherosclerosis. It is shown here that elicitation of IL-1 induced growth response requires a coordinated action with another priming growth factor such as PDGF. In this regard, IL-1 mediated proliferation of smooth muscle cells may have analogy with the IL-1 mediated T-cell activation and IL-2 production where concerted actions of antigen/mitogen and IL-1 are required.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784386     DOI: 10.1016/0014-4827(89)90104-3

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulation of interleukin-1.

Authors:  J Y Hsu; M Y Hsu; T Sorger; M Herlyn; E M Levine
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

Review 2.  Loss of CREB regulation of vascular smooth muscle cell quiescence in diabetes.

Authors:  Jane E B Reusch; Peter A Watson
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β.

Authors:  Youngho Lee; Daiko Wakita; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Ganghua Huang; Thomas J A Lehman; Michael C Fishbein; Hal M Hoffman; Timothy R Crother; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

Review 4.  Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.

Authors:  Jane C Burns; Isabelle Koné-Paut; Taco Kuijpers; Chisato Shimizu; Adriana Tremoulet; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

5.  Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).

Authors:  Adriana H Tremoulet; Sonia Jain; Susan Kim; Jane Newburger; Moshe Arditi; Alessandra Franco; Brookie Best; Jane C Burns
Journal:  Contemp Clin Trials       Date:  2016-04-11       Impact factor: 2.226

6.  Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis.

Authors:  C F Moyer; D Sajuthi; H Tulli; J K Williams
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

7.  PPARdelta inhibits IL-1beta-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra.

Authors:  H J Kim; M Y Kim; J S Hwang; H J Kim; J H Lee; K C Chang; J-H Kim; C W Han; J-H Kim; H G Seo
Journal:  Cell Mol Life Sci       Date:  2010-03-10       Impact factor: 9.261

8.  Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.

Authors:  R P Fabunmi; A H Baker; E J Murray; R F Booth; A C Newby
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

Review 9.  Consolidated and emerging inflammatory markers in coronary artery disease.

Authors:  Valter Lubrano; Silvana Balzan
Journal:  World J Exp Med       Date:  2015-02-20

10.  Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression.

Authors:  S K Gupta; J P Singh
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.